Tower Research Capital (TRC)’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $716K | Buy |
6,908
+3,025
| +78% | +$343K | 0.02% | 698 |
|
|
2025
Q4 | $392K | Sell |
3,883
-6,811
| -64% | -$739K | 0.01% | 971 |
|
|
2025
Q3 | $1.32M | Buy |
10,694
+3,483
| +48% | +$432K | 0.04% | 427 |
|
|
2025
Q2 | $866K | Buy |
7,211
+3,674
| +104% | +$490K | 0.02% | 613 |
|
|
2025
Q1 | $521K | Sell |
3,537
-7,840
| -69% | -$1.2M | 0.02% | 812 |
|
|
2024
Q4 | $1.85M | Buy |
11,377
+5,710
| +101% | +$934K | 0.04% | 392 |
|
|
2024
Q3 | $923K | Sell |
5,667
-6,267
| -53% | -$929K | 0.02% | 564 |
|
|
2024
Q2 | $1.63M | Buy |
11,934
+8,699
| +269% | +$1.21M | 0.03% | 515 |
|
|
2024
Q1 | $495K | Sell |
3,235
-12,854
| -80% | -$1.92M | 0.01% | 872 |
|
|
2023
Q4 | $2.29M | Buy |
16,089
+2,296
| +17% | +$306K | 0.03% | 468 |
|
|
2023
Q3 | $1.81M | Buy |
13,793
+6,663
| +93% | +$1.01M | 0.06% | 338 |
|
|
2023
Q2 | $1.13M | Buy |
7,130
+2,133
| +43% | +$344K | 0.04% | 437 |
|
|
2023
Q1 | $791K | Sell |
4,997
-938
| -16% | -$141K | 0.03% | 562 |
|
|
2022
Q4 | $833K | Sell |
5,935
-6,386
| -52% | -$906K | 0.03% | 451 |
|
|
2022
Q3 | $1.58M | Sell |
12,321
-15,723
| -56% | -$2.27M | 0.03% | 512 |
|
|
2022
Q2 | $3.95M | Sell |
28,044
-12,936
| -32% | -$1.85M | 0.09% | 191 |
|
|
2022
Q1 | $5.7M | Buy |
40,980
+29,772
| +266% | +$4.56M | 0.05% | 283 |
|
|
2021
Q4 | $1.95M | Buy |
11,208
+7,373
| +192% | +$1.23M | 0.03% | 420 |
|
|
2021
Q3 | $635K | Sell |
3,835
-1,503
| -28% | -$259K | 0.02% | 824 |
|
|
2021
Q2 | $960K | Sell |
5,338
-8,025
| -60% | -$1.46M | 0.03% | 689 |
|
|
2021
Q1 | $2.58M | Buy |
13,363
+8,297
| +164% | +$1.6M | 0.04% | 392 |
|
|
2020
Q4 | $1.02M | Buy |
5,066
+1,190
| +31% | +$246K | 0.03% | 513 |
|
|
2020
Q3 | $814K | Buy |
3,876
+147
| +4% | +$32.7K | 0.01% | 1177 |
|
|
2020
Q2 | $818K | Buy |
3,729
+3,513
| +1,626% | +$702K | 0.03% | 657 |
|
|
2020
Q1 | $37K | Buy |
+216
| New | +$35.7K | ﹤0.01% | 1420 |
|
|
2019
Q4 | – | Sell |
-86
| Closed | -$13K | – | 3631 |
|
|
2019
Q3 | $13K | Buy |
+86
| New | +$13.6K | ﹤0.01% | 2758 |
|
|
2019
Q2 | – | Sell |
-2,260
| Closed | -$363K | – | 3740 |
|
|
2019
Q1 | $363K | Sell |
2,260
-2,067
| -48% | -$321K | 0.02% | 811 |
|
|
2018
Q4 | $667K | Buy |
4,327
+3,844
| +796% | +$599K | 0.05% | 353 |
|
|
2018
Q3 | $73K | Buy |
483
+469
| +3,350% | +$66.6K | 0.01% | 1533 |
|
|
2018
Q2 | $2K | Buy |
+14
| New | +$1.73K | ﹤0.01% | 3310 |
|
|
2018
Q1 | – | Sell |
-514
| Closed | -$76K | – | 3315 |
|
|
2017
Q4 | $76K | Buy |
+514
| New | +$69.9K | 0.01% | 1042 |
|
|
2017
Q3 | – | Sell |
-146
| Closed | -$19K | – | 3810 |
|
|
2017
Q2 | $19K | Buy |
146
+126
| +630% | +$17K | ﹤0.01% | 1234 |
|
|
2017
Q1 | $3K | Sell |
20
-752
| -97% | -$97.4K | ﹤0.01% | 2445 |
|
|
2016
Q4 | $93K | Buy |
+772
| New | +$91K | 0.01% | 1008 |
|
|
2016
Q3 | – | Sell |
-1,016
| Closed | -$141K | – | 3719 |
|
|
2016
Q2 | $141K | Buy |
1,016
+940
| +1,237% | +$122K | 0.01% | 899 |
|
|
2016
Q1 | $10K | Buy |
+76
| New | +$9.66K | ﹤0.01% | 1940 |
|
|
2015
Q1 | – | Sell |
-75
| Closed | -$8K | – | 4443 |
|
|
2014
Q4 | $8K | Sell |
75
-289
| -79% | -$28.9K | ﹤0.01% | 2323 |
|
|
2014
Q3 | $35K | Buy |
364
+55
| +18% | +$4.97K | ﹤0.01% | 1831 |
|
|
2014
Q2 | $28K | Sell |
309
-76
| -20% | -$6.81K | ﹤0.01% | 1635 |
|
|
2014
Q1 | $34K | Buy |
385
+13
| +3% | +$1.14K | ﹤0.01% | 1372 |
|
|
2013
Q4 | $35K | Sell |
372
-513
| -58% | -$46.2K | 0.01% | 1710 |
|
|
2013
Q3 | $72K | Sell |
885
-127
| -13% | -$10.7K | 0.01% | 1594 |
|
|
2013
Q2 | $84K | Buy |
+1,012
| New | +$87.1K | 0.01% | 595 |
|
Other funds holding CLX
VCM
VPM
DAM
Tower Research Capital (TRC)'s CLX Position: Q1 2026 in Review
Tower Research Capital (TRC) increased its Clorox (CLX) stake by 78% in Q1 2026, buying an estimated $343K and bringing the position to 6,908 shares worth $716K. The position accounts for 0.02% of the portfolio, ranked #698.
Tower Research Capital (TRC) first reported a position in CLX in Q2 2013 and has held it in 43 quarters since. The position peaked at $5.7M in Q1 2022. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.
- Tower Research Capital (TRC) held 6,908 shares of Clorox worth $716K as of Q1 2026.
- Tower Research Capital (TRC) bought 3,025 Clorox shares in Q1 2026, an estimated $343K.
- Clorox made up 0.02% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #698 holding.
- Tower Research Capital (TRC) first reported a position in Clorox in Q2 2013 and has held it in 43 quarters since.
- Tower Research Capital (TRC)'s Clorox position peaked at $5.7M in Q1 2022.
- 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.